Pharma Tips

Aurobindo Pharma Limited

By: Pharma Tips | Views: 20523 | Date: 09-Sep-2012

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments

Aurobindo Pharma Limited

Overview
Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.

Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

Through cost effective manufacturing capabilities and a few loyal customers, the company entered the high margin specialty generic formulations segment. In less than a decade Aurobindo Pharma today has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients and formulation products. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries.

The formulation business is systematically organized with a divisional structure, and has a focused team for key international markets. Leveraging on its large manufacturing infrastructure for APIs and formulations, wide and diversified basket of products and confidence of its customers, it aims to achieve USD 2 billion revenues by 2015-16. Aurobindo's nine units for APIs / intermediates and seven units for formulations are designed to meet the requirements of both advanced as well as emerging market opportunities.

A well integrated pharma company, Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations. Our customers include premium multi-national companies.. With multiple facilities approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada and Brazil ANVISA, Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India.

Our Evolution
•    Successful innovation in process chemistry
•    Cost competitive manufacturing
•    Large diversified product portfolio
•    Global leadership in anti-infectives
•    Largest generic portfolio in Antiretroviral drugs (ARVs)


Core Strengths
Scales and Leadership
•    Large manufacturing facilities approved by leading regulatory bodies
•    Large diversified product portfolio
•    Large R&D facility in India for formulations and active ingredients

Operational Excellence
•    Vertical integration
•    Proven regulatory expertise
•    Technology and know-how for specialty formulations

Service Delivery
•    Global marketing network
•    Customer centric approach and relationship oriented marketing
•    Speed and effectiveness in execution with TQA

Robust R & D
One of the largest R&D facilities in India, Aurobindo Pharma has three research centres spread over 16000 square meters. The company employs over 650 scientists (including 35 PhDs). In-house expertise in product development ensures a quick turnaround time in areas such as:
•    Project / product identification
•    Literature evaluation / patent study
•    API process development
•    Formulation development
•    Pilot BA / BE
•    Exhibiting batches for dossier submission
•    Stability studies for global requirements
•    Dossier submission
Aurobindo is also associated with UNO for development of ARVs (Pediatric and fixed dose combinations). Apart from NDA filings, the company contributes to over 2300 dossier filings worldwide. It has established capabilities in Contract Research and Manufacturing Services (CRAMS) and regularly supplies impurity standards to the United States Pharmacopeial Convention (USP).

Mission & Vision
Vision

"To become Asia's leading generic Pharma company and one among the top 15 in the world, by 2015"

Mission
Aurobindo's mission is to become the most valued Pharma partner to the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards.

Our Values
BUSINESS CARE:
Business care is the continuous monitoring and improvement of performance indicators.
Operational Excellence is a continuous journey of excellence wherein every employee can see the flow of value to the customer and fix that flow when it fails to deliver.
Stakeholder Orientation means being responsive to a group or individual who are/is interested in the achievement of the firm's objectives.
Quality, is a measure of excellence or a state of being free from defects and innovision is discovering present and future business opportunities.

PEOPLE CARE:
It deals with the core philosophy of the management of human resources such as Talent Development, Talent Recognition, and Talent Welfare.
Fairness, humility and respect for individuals Appreciating each other's talent, ideas and treating all individuals in a consistently humble, fair and equal manner
Teamwork, is the capability of people within and among groups to continuously improve the performance.
Applied Learning Emphasis on Learn-by-Doing that empowers and upgrades skills of employees.

ORGANIZATION CARE:
It deals with the action and words of employees that lead to building a Greater Aurobindo. Accountability is to own up responsibility for outcome, leading to actualizing the commitment at work.
Integrity Steadfastness to honesty in our business transactions and interfaces .It involves conscience and consistent action by choice
Achievement A strong desire and drive to focus on performance and desired business results
Code of Conduct
Code of Conduct for Board Members and Senior Management
Introduction
•    This code of Conduct ("this Code") shall be called "The Code of Conduct for Board Members and Senior Management Personnel" of Aurobindo Pharma Limited (hereinafter referred to as "the Company").
•    This code has been framed specifically in compliance with the provisions of Clause 49 of the listing agreement entered into with stock exchanges.
•    The purpose of this code is to enhance further an ethical and transparent process in managing the affairs of the Company.
•    It has come in to force with effect from December 31st, 2005.

Definitions & Interpretations
•    The term "Board Members" shall mean Directors on the Board of Directors of the Company.
•    The term "Whole-time Director" shall be the Directors on the Board of Directors of the Company who are in whole-time employment of the Company.
•    The term "Part-time Director" shall mean Directors on the Board of Directors of the Company who are not in whole time employment of the Company.
•    The term "Senior Management Personnel" shall mean personnel of the Company in the cadre / designation of Senior Manager and above, excluding Board of Directors. Such personnel shall hereinafter be treated as members of its core management team.
•    The term "Relative" shall have the same meaning as defined in Section 6 of the Companies Act, 1956.

Applicability
•    This code shall be applicable to the following persons:
a) All whole-time Directors including the Chairman of the Company.
b) All part-time Directors.
c) All Senior Management Personnel.

Conflicts of Interest
•    The Directors and senior management should be scrupulous in avoiding 'conflicts of interest' with the Company. This is an area in which it is impossible to provide comprehensive guidance, but the guiding principle is that any event, activity or situation involving conflict or potential conflict of interest must be disclosed to the Board for guidance and appropriate action.
Honest and Ethical Conduct
•    The Directors and senior management shall act in accordance with the highest standards of personal and professional integrity, honesty and ethical conduct and use their powers of office, in good faith and in the best interests of the Company as a whole.
Corporate Opportunities
•    The Directors and senior management owe a duty to the Company to advance its legitimate interests when the opportunity to do so arises and are expressly prohibited from improper use of information or property or, taking improper advantage of their position.
Confidentiality
•    The Directors and senior management shall maintain the confidentiality of information of the Company or that of any customer, supplier or business associate of the Company to which the Company has a duty to maintain confidentiality, except when disclosure is authorized or legally mandated. The Confidential information includes all non-public information (including private, proprietary, and other) that might be of use to competitors or the disclosure of which might be harmful to the company or its Associates. The use of confidential information for his/ her own advantage or profit is also prohibited.
Protection and Proper Use of Company's Assets
•    The Directors and senior management should protect the company's assets and property. The company's assets should be used only for legitimate business purposes.
Compliance with Laws, Rules and Regulations
•    The Directors and senior management shall endeavor to ensure compliance with all applicable laws, rules, and regulations applicable to the Company. Transactions, directly or indirectly, involving securities of the Company should not be undertaken without complying with the Code of Conduct for Prohibition of Insider Trading.
Compliance with Code Of Conduct
•    All Directors and senior management personnel shall adhere to this code of conduct and affirm compliance with the code on an annual basis, as per the requirements of Clause 49 of the Listing Agreement with the Stock Exchanges. Violation of this Code will lead to appropriate action.

Our Operations
Catering to over 100 countries, Aurobindo Pharma has identified international operations as a major engine of growth and has since been expanding its global network of marketing and manufacturing operations. To help further expand its international reach, it concentrates its focus on such major countries as China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia and many more.
Powered by its subsidiary model, the brilliance and hard work of its global workforce, stellar track record, ever-growing infrastructure and cost-competitiveness, Aurobindo is well positioned to surmount the many challenges typically associated with the pharma industry.

Indian

Indian Subsidiaries:
APL Healthcare Limited
Plot No.2, Maitrivihar
Ameerpet
Hyderabad - 500 038.
Tel: +91 40 66725333
Contact Person: Mr. A. Mohan Rami Reddy
E-mail: cs@aurobindo.com
APL Research Centre Limited
Plot No.2, Maitrivihar
Ameerpet
Hyderabad - 500 038
Tel: +91 40 66725333
Contact Person: Mr. A. Mohan Rami Reddy
E-mail: cs@aurobindo.com

 
Auronext Pharma Private Limited
C-980, Sushant Lok Phase-1
Gurgaon - 122 015
Haryana
Tel: +91 124 4272602
Contact Person: Mr. B. R. Sikri
E-mail: auronext@gmail.com
Auro Peptides Limited
Plot No.2, Maitrivihar
Ameerpet
Hyderabad - 500 038.
Tel: +91 40 66725333
Contact Person: Mr. A. Mohan Rami Reddy
E-mail: cs@aurobindo.com

 
Aurobindo Antibiotics Limited
Plot No.2, Maitrivihar
Ameerpet
Hyderabad - 500 038.
Tel: +91 40 66725333
Contact Person: Mr. A. Mohan Rami Reddy
E-mail: cs@aurobindo.com


 
International Subsidiaries
Milpharm Limited
Ares Block,Odyssey Business Park,
South Ruislip, west end Road,
Middlesex, HA4 6QD,
United Kingdom.
Tel: +44 20 88458811
Contact Person: V. Muralidharan
E-mail: vmurali@aurobindo.com
Aurobindo Pharma Pty Ltd
53 Philip Engelbrecht Avenue,
Woodhill Office Park, Buiding No.1,
Meyersdal Ext. 12, 1448, Johannesburg,
South Africa.
Tel: +27 11 867 9100
Contact Person: Veekesh Galal
E-mail: Veekesh.galal@aurobindo.com


Novagen South Africa (JV)
53 Philip Engelbrecht Avenue,
Woodhill Office Park, Buiding No.1,
Meyersdal Ext. 12, 1448, Johannesburg,
South Africa.
Tel: +27 12 345 3175/1852
Contact Person: Johann Willemse
E-mail: johann@equitypharma.co.za
APL Pharma Thai Limited
436, 438 Phattanakarn,
30 Road Suanluang,
Bangkok-10250
Tel: +662 719 5425
Contact Person: Mr. M V Sastry
E-mail: mvsastry@aurobindo.com

Aurobindo Ilac Sanayi Ve Ticaret Ltd STI

Egitim Mh.Poyraz Sk.Sadikoglu Plaza 5,
No.27, Kadikoy Istanbul,
Turkey
Tel: 00 90 216 348 1076
Fax: 00 90 216 348 1768
Contact Person: Ms. Tugba Terecan Kiymaz
E-mail: tugba.kiymaz@aurobindo.com
Aurobindo Pharma (Malta) Ltd
Vault - 14, Level 2, Valletta Waterfront,
Floriana FLN 1913,
Malta
Tel: +356-9999 1441
Contact Person: Mr.Frederick Schembri
E-mail: fschembri@aurobindo.com

APL Swift services (Malta) Ltd
Vault - 14, Level 2, Valletta Waterfront,
Floriana FLN 1913,
Malta
Tel: +356 2701 4929
Contact Person: Mr. Frederick Schembri
E-mail: fschembri@aurobindo.com
Agile Pharma (Malta) Ltd
Vault - 14, Level 2, Valletta Waterfront,
Floriana FLN 1913,
Malta
Tel: +356-9999 1441
Contact Person: Mr. Frederick Schembri
E-mail: fschembri@aurobindo.com


Agile Malta Holdings

Vault - 14, Level 2, Valletta Waterfront,
Floriana FLN 1913,
Malta
Tel: +356-9999 1441
Contact Person: Mr. Frederick Schembri
E-mail: fschembri@aurobindo.com
Auropharma Inc.
1170 SheppardAve Unit # 16 Toronto,
Ontario M3K 2A3,
Canada
Tel: +1 416 633 2666
Contact Person: Suresh Kalidoss
E-mail: suresh@auropharma.ca


Aurohealthcare (Nigeria) Limited
Plot no.4, oyetubo street,
Off Obafemi, Awolowo Way,
Ikeja, Logos, Nigeria
Tel:
Contact Person: Guru Prasad
E-mail: guruprasad.kajakodi@aurobindo.com
Aurobindo Pharma USA Inc.
2400 Route 130 NorthDayton,
NJ 08810
Tel: +732 839 9400
Contact Person: Robert G. Cunard
E-mail: rcunard@aurobindousa.com


Aurolife Pharma LLC
2400 Route 130 North Dayton,
NJ 08810
Tel: +732 839 9400
Contact Person: Ram Biyani
E-mail: rbiyani@aurobindousa.com
Auromedics
2400 Route 130 North Dayton,
NJ 08810
Tel: +732 839 9400
Contact Person: Ronaldo F Quadrel
E-mail: rquadrel@aurobindousa.com


Aurobindo Pharma (Italia) S.r.l
Via Pergolesi,
15 20124 Milano
Italy
Tel: +39 02 89289800
Contact Person: Mr. Roberto Colauto
E-mail: roberto.colauto@aurobindo.com
Aurobindo Pharma France SARL
22 - 26 rue des Gaudines,
F-78 100 SAINT GERMAIN EN LAYE
France
Tel: +33 609 318105
Contact Person: Ms. Florence Bruneval
E-mail: bruneval.florence@aurobindo.com

Aurobindo Pharma GmbH
Carl von Linde Strasse 38,
85716 Unterschleissheim,
Rural Administrative district of Munich
Germany.
Tel: +49 175 438 0231
Contact Person: Mr. Alexander Fiedel
E-mail: alexander.fiedel@aurobindo.com
Aurobindo Pharma Japan KK
9th Floor, Youth Bldg.
1-3-8 Nihonbashibakuro-cho,
Chuo-ku, Tokyo, 103-0002
Japan
Tel: +81 3 3249 2261
Fax: +81 3 3249 0828
Contact Person: Mr. Nobuo Taku
E-mail: ntaku@aurobindo.com


APL Holdings (Jersey) Ltd
PO Box 51, 57, Bath street,
St. Helier, Je4 OXP,
Jersey, Channel Islands
Tel: +356 2701 4929
Contact Person: Mr. Frederick Schembri
E-mail: fschembri@aurobindo.com
APL IP company Ltd
PO Box 51, 57, Bath street,
St. Helier, Je4 OXP,
Jersey, Channel Islands
Tel: +356 2701 4929
Contact Person: Mr. Frederick Schembri
E-mail: fschembri@aurobindo.com


Laboratorios Aurobindo S.L
Avd. de la Industria 4 edificio 1,
oficina 2, Bajo B (Natea Business Center)
Alcobendas, Madrid (Spain)
Tel:+34 91 661 16 53
Contact Person: Mr. Gabriel Diaz
E-mail: Gabriel.diaz@aurobindo.com
Aurobindo Pharma Portugal
Av. do Forte, n.° 3, Parque Suécia,
Ed. IV, 2°, 2794-038 Carnaxide,
Portugal
Tel: +351 214 185 104
Contact Person: Mr. Pedro Merlini
E-mail: pedro.merlini@aurobindo.com


Aurobindo Pharma (Australia) (Pty) Ltd

Unit 3/277 - 284 Lane Cove Road
North Ryde, New South Wales 2113
Australia
Tel: +61 2 9805 6000
Fax no: +61 2 9887 1191
Contact Person: Mr Avinash Ramcharan
E-mail: avi@aurobindo.com
ALL Pharma (Shangai) Trading Co. Ltd
Room No 1401, Building ARoom No 1401, Building A
No 319, Xianxia Road, Shanghai, P.R, China
Contact Person: Mr. Arvind Chandak
E-mail: arvind@aurobindo.com


Pharmacin B.V
Molenvliet 103, 3335 LH Zwinjdrecht,
The Netherlands.
Tel: +31 (0) 78610 18 36
Contact Person: Mr. Ronaldo Steentjes
E-mail: r.steentjes@pharmacin.nl
Helix healthcare B.V
Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands
Post Bag No. 990 1000 AZ
Amsterdam,
The Netherlands
Tel: +3 120 521 4671
Contact Person: Mr. Gunther Warris
E-mail: gunther.warris@intertrustgroup.com


Agile Pharma B.V
Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands
Post Bag No. 990 1000 AZ
Amsterdam,
The Netherlands
Tel: +3 120 521 4671
Contact Person: Mr. Gunther Warris
E-mail: gunther.warris@intertrustgroup.com
Aurobindo Pharma productos Farmaceuticos LTDA
VP-06E QD.09 MÓD. 12/15
Daia, Anapolis Golas (STATE)
CEP(PIN) 75-132-135
Tel: +55 62 40153400 / 40153410
Contact Person: Mr. S B Reddy
E-mail: sbreddy@aurobindo.com


Aurobindo Pharma Industrial Pharmaceuticla LTD

VP-06E QD.09 MÓD. 12/15
Daia, Anapolis Golas (STATE)
CEP(PIN) 75-132-135
Tel: +55 62 40153400 / 40153410
Contact Person: Mr. C S Balaji
E-mail: balajics@aurobindo.com
Aurobindo Pharma BV
Molenvliet 103
3335 LH Zwinindrecht,
The Netherlands
Contact Person: Mr. Ronaldo Steentjes
E-mail: r.steentjes@pharmacin.nl


Aurobindo Pharma Romania SRL
Bucharest, Paneologu street No.24
2nd floor, Room No. E02
3RD Dist, Romania
Contact Person: Mr. V. Muralidharan
E-mail: vmurali@aurobindo.com
Aurobindo Pharma (Poland) SP.Z.O.O
Al.Jerozolimskie
56c,00-803
Warsaw, Poland
Contact Person: Mr. V. Muralidharan
E-mail: vmurali@aurobindo.com


Aurobindo Pharma (Singapore) pte Ltd
10 Jalan Besar,
#10-10 Sim Lim Tower
Singapore 208787
Contact Person: Mr. Rajiv Sharma
E-mail: rajiv.sharma@aurobindo.com
Aurobindo Pharma Limited srl
4 Poncio Sabater Street, Paraiso
Santo Domingo, Dominican Republic
Contact Person: Mr. Suresh Kalidoss
E-mail: suresh@auropharma.ca


Aurobindo Pharma NZ Limited
64, Saddleback grove, Karori,
Wellington, New Zealand 6012
Contact Person : Mr. Avinash Ramcharan
Email : avi@aurobindo.com
Aurovida Farmaceutica SA DE CV
Rio Tiber 91 401, Cuauhtemoc,
Distrito Federal 06500 DR
Mexico
Contact Person : Mr. Michael Padvaiskas Ackerman
Email: mikep@farmagen.com.mx


Branch / Representative Offices

Ethiopia
Aurobindo Pharma Limited

C/o. Mesroy International PLC, Nifas Silk,
Lafto/Kifle Detema Kebele-06, House No. 071,
P.O. Box 27322, Addis Ababab,
Ethiopia.
Tel:
Contact Person: Mr. Aravind Babu
E-mail: aravindbabum@aurobindo.com
Ghana
Aurobindo Pharma Limited

P.O.Box 260,
Latekiobioshire, Accra,
Ghana.
Tel:
Contact Person: Mr. K V Guruprasad
E-mail: guruprasad.kajakodi@aurobindo.com


Vietnam
Aurobindo Pharma Limited
12M, Nguyen Thi Minh Khai St. Hong Dan Building,
4th Floor, District 1, Ho Chi Min City,
Vietnam.
Tel: ++84-839103947
Contact Person: Mr. Subramonian Parameswaran Iyer
E-mail: subu@aurobindo.com

United Kingdom
Aurobindo Pharma Limited

Ares Block, Odyssey Business Park,
South Ruislip, west end Road,
Middlesex, HA4 6QD,
United Kingdom.
Tel: ++ 44 20 8845 8811
Contact Person: Mr. V. Muralidharan
E-mail: vmurali@aurobindo.com


Hong Kong
Aurobindo Pharma Limited

Unit 5, 13 - A/F, Koon Wah Mirror Factory,
3rd Industrial Building,
5-9, Ka Hing Road,
Kwai Chung, NT,
Hong Kong.
Tel: ++ 852 91 897 008
Contact Person: Mr. Rajat Chowdhury
E-mail: rajiv.sharma@aurobindo.com

Russia
Aurobindo Pharma Limited

Entrance No.1 & 2nd Floor,
LLC Yura Trade,
Mikhalkovskaya Ulitsa Dom 63B KOR.1,
Moscow - 125438,
Russia.
Tel:
Contact Person: Mr. Jayapala Reddy
E-mail: jayapalareddy@aurobindo.com


Kenya
Aurobindo Pharma Limited

C/o. Simba Pharmaceuticals
Centenary House
Ground Floor, Ring Road
Off: Raphta Road, West Lands
P O Box 1541-00606,
Nairobi,
Kenya.
Tel: +2547395799
Contact Person : Mr Satish Nagaraj
Email : satish.nagaraj@aurobindo.com
Tanzania
Aurobindo Pharma Limited
C/o Generics and Specialties
P O Box 1469 , Dar Es Salam
Tanzania.
Tel:+255752786199
Contact Person : Mr Vipin P A
Email : vipin.abraham@aurobindo.com


Corporate Governance
The Board has a good mix of pharmaceutical experience and professional management. Decision-making is decentralized, with accountability and freedom to operate.
Under the leadership and supervision of the Board of Directors assisted by a qualified and experienced team of professionals in the fields of production, research and development, marketing, HR, finance, purchase and administration, Aurobindo Pharma has successfully integrated its operations. All projects have been implemented with no cost or time overruns.
All major decisions are made globally after consultation with experienced professionals in their specific areas of activity. Decisions and execution are targeted to derive value addition in everything that the company does.
Operations are conducted with utmost financial discipline. The management follows up to ensure that trust in employees is reciprocated with fairness in all dealings.
All decisions are taken in the interest of shareholders. The Board and management are aware and conscious of the interests of minority shareholders and do everything to enhance shareholder value in totality.
The company is keen to share its gains and has a decent dividend record. The company has also been issuing bonus shares from time to time. Value creation for shareowners is a cornerstone and is being consistently followed.
Committees of directors are to be appointed to focus on specific areas. Aurobindo Pharma is going through a process of transformation in a professional environment.
The Board of Directors meets as often as business demands, and all meetings are well attended.

Formulations
Overview

Aurobindo Pharma Ltd. is a vertically integrated pharmaceutical company that delivers innovative solutions. From discovery to development to commercialization, our growth is aided by cost-effective drug development and substantial manufacturing.
Leveraging India's globally competitive cost base and talented team of scientists, we have successfully launched a range of affordable products which are accessible across the globe.

Accreditations
We have eight state-of-the-art formulation manufacturing facilities located in India, USA and Brazil. Our facilities have received accreditations from the following regulatory bodies:
 
•    US FDA (United States Food and Drug Administration)
•    UK's MHRA (United Kingdom's Medicines and Health products Regulatory Agency)
•    TGA Australia (Therapeutic Goods Administration)
•    MCC South Africa (Medicines Control Council)
•    ANVISA Brazil (National Health Surveillance Agency)
•    Health Canada and
•    GCC DR (Gulf Central Committee for Drug Registration

Manufacturing capabilities
Aurobindo has retained the same drive for growth that marked its early days. Starting off with a small SSP manufacturing unit in 1988, Aurobindo has grown to become the market leader in SSPs, non penicillins, cephalosporins, and non cephalosporins. In the global market, we believe in retaining our leadership in SSPs, cephalosporins, new anti-infectives and lifestyle disease drugs.

Our core strengths:
•    Vertically integrating the operations from conception to commercialization.
•    Larger manufacturing capabilities for a diversified product portfolio.
•    Efficient regulatory affairs team designed for market compliance.
•    Dedicated R&D setup for finished dosages and active ingredients.
•    Technology and expertise for specialty formulations
Our key formulation facilities (6 in India, 1 each in the US and Brazil):
Unit 3
•    An exclusive multi-product oral dosage form facility spread over 40,469 sq. meters for non cephalosporins and non beta-lactams
•    Spread over 40,469 sq. meters.     
Unit 4
•    A dedicated manufacturing facility for generic sterile injectables (lyophilized and powder injections, prefilled syringes), opthalmics and low volume parenterals.
•    The facility is spread over 33 acres with a built-up area of 20,000 square. meters.     
Unit 6
•    A dedicated facility spread over 58,060 square. meters for manufacturing oral and sterile cephalosporin formulations.
•    Spread over 58,060 sq. meters.     
Unit 7
•    An ultra modern unit based on the suite manufacturing concept for huge capacities.
•    Manufactures non penicillins, non cephalosporins & ARVs     
Unit 12
•    A dedicated facility spread over 15,228 square. meters.for manufacturing oral and sterile beta-lactam formulations.
•    Spread over 15,228 sq. meters.     
Auronext
•    To produce sterile penem formulations.
•    Also manufactures sterile APIs      
Aurolife (Located in the US)
•    A 100,000 square feet state-of-the-art USFDA approved cGMP compliant manufacturing facility located in New Jersey
•    Manufactures non-pencillins and non-cephalosporin products     
Brazil
•    Have an exclusive manufacturing facility for SSPs, which caters to the requirements of Latin America

Business Models   

Aurobindo has a sustainable network of alliances and partnerships across the globe. The company has carved a niche for itself in the global regulated market.
We aspire to:
•    Grow through territory expansions, partnerships, globalization & further penetration through joint ventures and subsidiaries in potential markets
•    Develop a broad portfolio of products through non-infringing processes and become a significant player in the generics arena.
•    Emerge as a leading global player in high quality, innovative specialty generic formulations.
 
Geographic presence
Aurobindo Pharma is one of the well-known global suppliers of generic Antiretroviral (ARV) drugs. we because of its high customer centricity. Our products are updated continuously to suit the changing needs of our customers. We market more than 300 products in over 125 countries. We are building and establishing our brands as we gain significant strengths in chosen markets. We have strategic alliances with global pharmaceutical majors to cater to their formulation manufacturing needs. Aurobindo Pharma is one of the well-known global suppliers of generic Antiretroviral (ARV) drugs.

API
Overview

Aurobindo is one of the top API manufacturing companies in the world and also one of the very few pharmaceutical companies that are vertically integrated with a presence in the API and Formulations segments. This makes Aurobindo a truly formidable, fully integrated global pharmaceutical company.
By maintaining cost leadership and competitiveness in various therapeutic domains, Aurobindo's API business has ensured the profitability and growth of the company's Formulation business in addition to being a top API supplier globally.
We are one among the very few players present across betalactams and non-betalactams. In betalactams we offer both sterile and non-sterile penicillin and cephalosporins along with penams. This was achieved by focusing on improving operational efficiencies with a careful and meticulous product selection strategy based on real time market requirements. By maintaining cost leadership, the flexibility to switch manufacturing operations and, the competitiveness in various therapeutic domains, Aurobindo's API business has been in the top league, globally.

Development and Manufacturing

Our API business is supported by technologically advanced API research and development infrastructure, which develops new products and is engaged upto the delivery of products to the market.
The API research division is housed in a sprawling 15-acre campus with a built up area of over five hundred thousand square feet which houses both chemical and analytical research along with a kilo lab. With experience of commercializing over 200 APIs, the research team is completely attuned to our growth aspirations. Committed to quality, safety and the environment, five of our manufacturing facilities have been inspected and approved by the US FDA, UK MHRA, TGA Australia, ANVISA and other reputed regulatory agencies.
Our state-of-the-art manufacturing plants ensure that we deliver quality and scale. We have successfully integrated our capabilities and capacities to deliver a wide product portfolio that caters to the needs of diverse markets. Aurobindo operates dedicated facilities for categories from intermediates to oral and sterile betalactams. There are multiple site filings to mitigate the supply risk and to ensure business continuity. Aurobindo API plants are equipped with particle size modifications systems to supply compacted and micronized materials.
Manufacturing is backed by warehousing systems that offer ambient control room temperature (CRT) and cold rooms. API plants are equipped by site dedicated quality control laboratories. We practice DIMAP, FEMA methodologies as part of our QMS.
We offer the complete bandwidth of products in Penicillins, Cephalosporins, Anti-retroviral, Anti-infectives and other non betalactams. We also offer sterile and non sterile anti-biotics.

Regulatory History
Aurobindo has a very strong track record in the regulatory filings. We have applied for 150 US DMFs and about 2000+ filings in other countries. Aurobindo has close to 500 patents in place.
HR Philosophy
HR Vision
"To make APL as a Learning organization towards sustained business performance through progressive talent management."

HR Mission
•    To attract ,build and retain right talent at all levels.
•    To create and nurture performance culture through continuous capability building, performance measurement and leveraging IT.
•    To foster leadership at all levels through trust, empowerment & openness.
•    To strengthen collaborative approach for Business Excellence.
•    Promote a vibrant work culture based on innovation and incentivize people based on productivity/outstanding performance .
Current Openings  click here http://www.aurobindo.com/careers/current-openings

Reach Us
Registered & Corporate Office
Plot # 2, Maitri Vihar,
Ameerpet,
Hyderabad - 500 038,
Andhra Pradesh, India.
Phone: +91 (40) 6672 5000
Fax: +91 (40) 2374 1080 / +91 (40) 2374 6833,
Email: info@aurobindo.com
Aurobindo Pharma USA INC.,
6, Wheeling Road,
Dayton, NJ 08810,
USA
API enquiries for North America and Canada
Contact Person: Rajeev TL
Email: rajeevtl@aurobindousa.com

 
For Job Applications: hr@aurobindo.com

All other enquiries: info@aurobindo.com

 
AuroSource Crams Division
Contact Person: Dr Vijay Kaiwar
Head Business Development - CRAMS,
AuroSource ( A Division of Aurobindo Pharma Ltd),
APL Research Centre-2,
Survey No. 71 & 72, Indrakaran Village,
Sanga Reddy Mandal, Medak District.
Andhra Pradesh, Pin: 502 329, INDIA.
Phone: +91 8455223824
Email: Vijay.Kaiwar@aurobindo.com
Pharmaco Vigilance
Contact Person: Dr Samikha Gupta
Board No: 91 40 23040261
Direct Extension No: 1446
Email: pharmacovigilance@aurobindo.com

 
API
Contact Person: Prabhakar Reddy
Board No: 91 40 66725000
Direct No: 91 40 66725178
Email: Prabhakar@aurobindo.com
US/EU( formulations)
Contact Person: Rajanikanth
Board No: 91 40 23044060
Direct No: 91 40 23044736
Email: Rajanikanth.kamalapuram@aurobindo.com

 
Emerging Market( formulations)
Contact Person: Vishnu Sriram
Board No: 91 40 23044060
Direct No: 91 40 23040683
Email: em@aurobindo.com
ARV( Formulations)
Contact Person: Umesh K
Board No: 91 40 23044060
Direct No: 91 40 23046916
Email: ARV@aurobindo.com


Products of Aurobindo


•ALFAZOSIN
•AURONIM
•AUROX 150
•AUROX 50MG
•AUROX-KID
•AUTIDINE
•AXTL
•BROX
•CEDBROX
•CEFACTAM
•CEFTRAX
•IVCEF
•LAMIVOX
•LINTAZ
•NEIVEX
•PLX
•PROXTL
•RECIPRO
•RECIPRO T
•RECIPRO TS
•RENOR
•RENOR TI
•RIDODIA
•STAVEX 40 LN
•STAVEX
•TOPRAZ
•TREONAM
•TRIPCUT
•VIRANZ
•Z PLUS L
•Z PLUS
•ZCIL
•ZOLCER

Previous Page Next Page

People Searching On This Page:
  • type of formulation in aurobindo unit 2
  • Aurobindo Pharma unit 11 view
  • Aurabindho Unit 5
  • where in Aurobindo Pharma unit 6
  • www.Aurobindo pvt ltd unit XI
  • aurobindo pondicherry pharma company address
  • aurobindo freshers vacancies unit12
  • Milpharm Limited Ares Block,Odyssey Business Park, South Ruislip, west end Road, Middlesex, HA4 6QD, United Kingdom. Tel: 44 20 88458811 Contact Person: Mr.V. Muralidharan E-mail: vmurali@aurobindo.com
  • aurobindo pharma unit 11 contactnumber
  • Aurobindo Pharma Limited Unit 5
  • aurobindo pharma
  • mail e-learning nl loc:IN
  • office buchule-hr.co.za loc:IN
  • info krey-partner.de loc:IN
  • info apl.in loc:IN

Related Pages


BSC/ MSC/ B.Pharma/ M.Pharma Jobs as Quality Assurance Jobs in Sun Pharma

BSC/ MSC/ B.Pharma/ M.Pharma Jobs as Quality Assurance Jobs in Sun Pharma

Jobs | Quality Assurance
Date:
21-Dec-2016  Views: 40880

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth ...
Walk-in interview for B.Pharma, M Pharma, BSC, MSC in Ipca Lab

Walk-in interview for B.Pharma, M Pharma, BSC, MSC in Ipca Lab

Jobs | Quality Assurance | Gujarat
Date:
02-Dec-2016  Views: 12829

Ipca Laboratories Ltd Ipca high brand equity in the Domestic & International plant, Our manufacturing facilities from the word's most vigilant reg ...
Career for Fresher B.Pharma/ M.Pharma at Caliber Technologie

Career for Fresher B.Pharma/ M.Pharma at Caliber Technologie

Jobs
Date:
20-Apr-2016  Views: 1615

Caliber Technologies Pvt. Ltd. is a company formed in Aug 2001 with a focus on solutions for Pharma and biotech industries. Caliber's core competency ...
Freshers B.Pharma, M.Pharma as QA, QC, MFG Jobs in Tescos Life care

Freshers B.Pharma, M.Pharma as QA, QC, MFG Jobs in Tescos Life care

Jobs
Date:
18-Feb-2016  Views: 2002

We are the manufacturer and exporter of pharmaceuticals from Rohini Delhi our factories at Bahadurgarh and Roorkee have requirement for QC/QA/MFG depa ...
Pharmacy Laws and Federal Acts related to Pharmacy Technicians

Pharmacy Laws and Federal Acts related to Pharmacy Technicians

Articles | PCI Registration
Date:
11-Sep-2014  Views: 3497

Pharmacy laws is made at local, state and federal levels.For the purpose of studying for the PTCB or ExCPT exams it is necessary to know the federal a ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

17  + 5 =     
Comments
People Searched About:
Type Of Formulation In Aurobindo Unit 2   |   Aurobindo Pharma Unit 11 View   |   Aurabindho Unit 5   |   Where In Aurobindo Pharma Unit 6   |   Www.Aurobindo Pvt Ltd Unit XI   |   Aurobindo Pondicherry Pharma Company Address   |   Aurobindo Freshers Vacancies Unit12   |   Mail E-Learning Nl Loc:IN   |   Office Buchule-Hr.Co.Za Loc:IN   |   Info Krey-Partner.De Loc:IN   |   Info Apl.In Loc:IN   |   Info Huge.Co.Za Loc:IN   |   Info Goodmix.Com.Br Loc:IN   |   Info Gcc.Az Loc:IN   |   Aurobindo Pharmaceuticals Australia Growth   |   @Aurobindo.Com   |  
Google : 1391 times | Yahoo : 11 times | Bing : 176 times |